High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 4, 1998, Pages 1143-1150

  Holte, Jan ^a,b   Gennarelli, Gianluca ^a   Wide, Leif ^a   Lithell, Hans ^a   Berne, Christian ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; FOLLITROPIN; GLUCOSE; GROWTH HORMONE; INSULIN; LIPID; LUTEINIZING HORMONE; SEX HORMONE; TESTOSTERONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HIRSUTISM; HUMAN; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MATERNAL HYPERTENSION; MENSTRUATION DISORDER; OVARY POLYCYSTIC DISEASE; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL;

FALLOPIA;

EID: 0031791823     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.4.4707     Document Type: Article

References (63)

1. Metzger BE. 1991 Summary and recommendations of the third international workshop-conference on gestational diabetes. Diabetes. 40(Suppl 2):197-201.
2. Hadden DR. 1980 Screening for abnormalities of carbohydrate metabolism in pregnancy. Diabetes Care. 3:440-446.
3. Hadden DR. 1985 Geographic, ethnic and racial variation in the incidence of gestational diabetes mellitus. Diabetes. 34(Suppl 2):8-12.
4. Dornhorst A. 1994 Implications of gestational diabetes for the health of the mother. Br J Obstet Gynaecol. 101:286-290.
5. Damm P, Kuhl C, Bertelsen A, Molsted-Pedersen L. 1992 Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol. 167:607-616.
6. Ryan EA, O'Sullivan MJ, Skyler JS. 1985 Insulin action during pregnancy: studies with the euglycemic clamp technique. Diabetes. 34:380-389.
7. Buchanan TA, Metzger BE, Freinkel N, Bergman RN. 1990 Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol. 162:1008-1014.
8. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EAH. 1991 Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 165:1667-1672.
9. Ryan EA, Imes S, Liu D, et al. 1995 Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes. 44:506-512.
10. Chang RJ, Nakamura RM, Judd HL, Kaplan SA. 1983 Insulin resistance in non-obese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 57:356-362.
11. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1165-1174.
12. Robinson S, Chan SP, Spacey S, Anyaoku V, Johnston DG, Franks S. 1992 Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clin Endocrinol (Oxf). 36:537-543.
13. O'Meara NM, Blackman JD, Ehrman DA, et al. 1993 Defects in β-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 76:1241-1247.
14. Holte J, Bergh T, Berne C, Berglund L, Lithell H. 1994 Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 78:1052-1058.
15. Holte J. 1996 Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Bailliere Clin Endocrinol Metab 10:221-247.
16. Polson DW, Adams J, Wadsworth J, Franks S. 1988 Polycystic ovaries-a common finding in normal women. Lancet. 1:870-872.
17. Clayton RN, Ogden V, Hodgkinson J, et al. 1992 How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf). 37:127-134.
18. Plehwe WE, Maitland JE, Williams PF, Shearman RP, Turtle JR. 1985 Familial hyperinsulinemia complicated by extreme insulin resistance during pregnancy: a probable postreceptor defect. J Clin Endocrinol Metab. 61:68-77.
19. Lanzone A, Caruso A, Di Simone N, De Carolis S, Fulghesu AM, Mancuso S. 1995 Polycystic ovary disease. A risk factor for gestational diabetes? J Reprod Med. 40:312-316.
20. Wortsman J, de Angeles S, Futterweit W, Singh KB, Kaufmann RC. 1991 Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome. J Reprod Med. 36:659-661.
21. Ferrannini E, Buzzigoli G, Bonadonna RC. 1987 Insulin resistance in essential hypertension. N Engl J Med. 317:350-357.
22. Pollare T, Lithell H, Berne C. 1990 Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 39:167-174.
23. Sowers JR, Abdelaziz AS, Sokol RJ. 1995 Hyperinsulinemia and insulin resistance are associated with preeclampsia in african-americans. Am J Hypertens. 8:1-4.
24. Adams J, Polson DW, Franks S. 1986 Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J. 293:355-359.
25. Hatch R, Rosenfield RL, Kim MH, Tredway D. 1981 Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 140:815-830.
26. WHO. 1985 Diabetes mellitus: report of a study group. Geneva: WHO; Tech Rep Ser 727.
27. De Fronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:214-223.
28. Holte J, Bergh T, Berne C, Lithell H. 1994 Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin Endocrinol (Oxf). 41:463-471.
29. Holte J, Bergh T, Gennarelli G, Wide L. 1994 The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopnusal women. Clin Endocrinol (Oxf). 41:473-481.
30. Carlström K, Gershagen S, Rannevik G. 1987 Free testosterone and testosterone/SHBG index in hirsute women: a comparison of diagnostic accuracy. Gynecol Obstet Invest. 24:256-261.
31. Brownlee KA. 1965 Statistical theory and methodology in science and engineering, 2nd ed. New York: Wiley and Sons.
32. Botsis D, Kassanos D, Pyrgiotis E, Zourlas PA. 1995 Sonographic incidence of polycystic ovaries in a gynecological population. Ultrasound Obstet Gynecol. 6:182-185.
33. Yen SSC. 1980 The polycystic ovary syndrome. Clin Endocrinol (Oxf). 12:177-208.
34. Franks S. 1995 Polycystic ovary syndrome. N Engl J Med. 333:853-861.
35. Franks S. 1989 Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf). 31:87-120.
36. Rebuffé-Scrive M, Cullberg G, Lundberg PA, Lindstedt G, Björntorp P. 1989 Anthropometric variables and metabolism in poly cystic ovarian disease. Horm Metab Res. 21:391-397.
37. Bringer J, Lefebvre P, Boulet F, et al. 1993 Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles. Ann NY Acad Sci. 687:115-123.
38. Poretsky L, Piper B. 1994 Insulin resistance, hypersecretion of LH, and a dual-effect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet Gynecol. 84:613-21.
39. Barbieri RL, Smith S, Ryan KJ. 1988 The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril. 50:197-212.
40. Plymate SR, Matej LA, Jones REF, KE. 1988 Inhibition of sex hormone-binding globulin production in human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 67:460-464.
41. Dunaif A, Finegood D. 1996 B-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 81:942-947.
42. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS. 1995 Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 96:520-527.
43. Holte J, Bergh T, Berne C, Wide L, Lithell H. 1995 Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 80:2586-2593.
44. Holte J, Gennarelli G, Berne C, Bergh T, Lithell H. 1996 Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state? Hum Reprod. 11:23-28.
45. Berne C, Fagius J, Pollare T, Hjemdahl P. 1992 The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia. 35:873-879.
46. Laivuori H, Tikkanen MJ, Ylikorkala O. 1996 Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab. 81:2908-2911.
47. Reaven GM. 1988 Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
48. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. 1992 Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf). 37:119-125.
49. Norman RJ, Masters SC, Hague W, Beng C, Pannall P, Wang JX. 1995 Metabolic approaches to the subclassification of polycystic ovary syndrome. Fertil Steril. 63:329-335.
50. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. 1992 Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand. 71:599-604.
51. Talbott E, Guzick D, Clerici A, et al. 1995 Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol. 15:821-826.
52. Sampson M, Kong C, Patel A, Unwin R, Jacobs HS. 1996 Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Clin Endocrinol (Oxf). 45:623-629.
53. Norman RJ, Hague WM, Master SC, Wang XJ. 1995 Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum Reprod. 10:2258-2261.
54. Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. 1984 Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism. 33:68-75.
55. Björntorp P. 1988 Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev. 4:615-622.
56. Kissebah AH, Peiris AN. 1989 Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev. 5:83-109.
57. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. 1983 Effect of fatty acids on glucose production and utilization in man. J Clin Invest. 72:1737-1747.
58. Glass AR. 1989 Endocrine aspects of obesity. Med Clin North Am. 73:139-160.
59. Insler V, Shoham Z, Barash A, et al. 1993 Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings. Hum Reprod. 8:379-384.
60. Slowinska SJ, Zgliczynski W, Makowska A, et al. 1992 An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity. J Clin Endocrinol Metab. 74:1432-1435.
61. Lanzone A, Villa P, Fulghesu AM, Pavone V, Caruso A, Mancuso S. 1995 The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary syndrome: relationship with obesity and hyperinsulinaemia. Hum Reprod. 10:1653-1657.
62. Piaditis GP, Kounadi TG, Rangou DB, et al. 1995 Dysfunction of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovarian syndrome. Clin Endocrinol (Oxf). 42:635-640.
63. Morales AJ, Laughlin GA, Butzow T, Maheshwari H, Baumann G, Yen SSC. 1996 Insulin, somatotropic, and luteinizing hormone axis in lean and obese women with polycytsic ovary syndrome: common and distinct features. J Clin Endocrinol Metab. 81:2854-2864.